IL-3 increases marrow and peripheral erythroid precursors in chronic pure red cell aplasia presenting in childhood.

Bastion, Y; Campos, L; Roubi, N; Bienvenu, J; Felman, P; Dumontet, C; Coiffier, B

Bastion, Y; Campos, L; Roubi, N; Bienvenu, J; Felman, P; Dumontet, C; Coiffier, B.

Affiliation

Bastion Y; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.

Br J Haematol ; 89(2): 413-6, 1995 Feb.

Article in En | MEDLINE | ID: mdl-7873394

Subject(s)

Fanconi Anemia/therapy; Interleukin-3/therapeutic use; Red-Cell Aplasia, Pure/therapy; Adult; Bone Marrow/pathology; Dose-Response Relationship, Immunologic; Erythroid Precursor Cells/physiology; Erythropoietin/therapeutic use; Fanconi Anemia/blood; Female; Hematopoietic Stem Cells/physiology; Humans; Middle Aged; Red-Cell Aplasia, Pure/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-3 / Red-Cell Aplasia, Pure / Fanconi Anemia Limits: Adult / Female / Humans / Middle aged Language: En Journal: Br J Haematol Year: 1995 Document type: Article Affiliation country: France Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links